Foundry Group's Jason Mendelson to Keynote Michigan Growth Capital Symposium

Midwest’s Leading Venture Capital Event Also Unveils Partial List of Presenting Companies
1341

ANN ARBOR — Organizers of the Michigan Growth Capital Symposium announced that Jason Mendelson, co-founder and managing director of Foundry Group, will deliver the opening keynote address at the 31st annual event. Mendelson will provide the event’s opening keynote address, which will be followed by a program of panels and presentations from 32 startups seeking funding ranging from half a million to $20 million. A partial list of these presenting companies was also revealed Friday.

“There’s a perfect storm of activity happening in Michigan, including incentives offered by the state, further development of the entrepreneurial community and sizable investments in R&D from local universities,” said David J. Brophy, founder and director of the Symposium and professor of finance at the University of Michigan Ross School of Business. “People are now paying close attention to activity here.”

Mendelson, a Michigan native and graduate of the University of Michigan, will provide attendees with his view on the state of the Michigan venture capital investment landscape and the factors driving its marked success over the past five years. He will also present on the energy found in the state and how those involved in the regional investment community can connect with recognized investors from across the U.S. and maximize the momentum created.

Mendelson has over a decade of experience in the venture capital and technology industries in a multitude of investing, operational and engineering roles. He co-founded Foundry Group, a Boulder, Colo.-based venture capital firm focused on making investments in early-stage information technology, Internet and software startups, most notably Zynga.

A total of 32 emerging startups from the Midwest and beyond will present at the Symposium. The companies represent high growth industries such as medical devices, information technology and mobile, and many are drawn on technology commercialized at the state’s robust University research corridor.  Here is a sample of this year’s presenting companies:

*Swift Biosciences (Michigan) – develops enabling technologies for genomics and personalized medicine

*Commuter Advertising (Ohio) – provides active and entertaining audio advertising onboard public transit vehicles

*NeuWave Medical (Wisconsin) – specializes in developing and commercializing energy-based minimally invasive medical devices medical devices

*Alert Communications (Michigan) – a refurbisher and wholesale distributor of mobile phones

*Atterocor (Michigan) – a research and development company focused on therapeutics for adrenal disease

*Vestaron (Michigan) – developing a new generation of insecticides derived from peptides produced by spiders

The complete list of presenting companies will be made available on the Symposium’s website on May 8.

Presented by the University of Michigan Zell Lurie Institute’s Center for Venture Capital & Private Equity Finance at the Ross School of Business with support from the Michigan Venture Capital Association, this year’s Symposium will be held May 15-16 at the Marriott Resort in Ypsilanti.  To learn more or register to attend the Symposium, visit www.MichiganGCS.com.